Dataset Information


Efficacy and safety of three regimens for the prevention of malaria in young HIV-exposed Ugandan children: a randomized controlled trial.

ABSTRACT: Trimethoprim-sulfamethoxazole prophylaxis is recommended for HIV-exposed infants until breastfeeding ends and HIV infection has been excluded. Extending prophylaxis with a focus on preventing malaria may be beneficial in high transmission areas. We investigated three regimens for the prevention of malaria in young HIV-exposed children.An open-label, randomized controlled trial.Tororo, Uganda, a rural area with intense, year-round, malaria transmission.Two hundred infants aged 4-5 months enrolled and 186 randomized after cessation of breastfeeding and confirmed to be HIV uninfected (median 10 months of age).No chemoprevention, monthly sulfadoxine-pyrimethamine, daily trimethoprim-sulfamethoxazole or monthly dihydroartemisinin-piperaquine given from randomization to 24 months of age.The primary outcome was the incidence of malaria during the intervention period. Secondary outcomes included the incidence of hospitalization, diarrhoeal illness, or respiratory tract infection; prevalence of anaemia and asymptomatic parasitemia; measures of safety; and incidence of malaria over 1 year after the intervention was stopped.During the intervention, the incidence of malaria in the no chemoprevention group was 6.28 episodes per person-year at risk. Protective efficacy was 69% [95% confidence interval (95% CI) 53-80, P?


PROVIDER: S-EPMC4487368 | BioStudies | 2014-01-01

REPOSITORIES: biostudies

Similar Datasets

2016-01-01 | S-EPMC4847718 | BioStudies
2020-01-01 | S-EPMC7303957 | BioStudies
2014-01-01 | S-EPMC4122345 | BioStudies
2016-01-01 | S-EPMC4831156 | BioStudies
2019-01-01 | S-EPMC6351525 | BioStudies
2018-01-01 | S-EPMC5968371 | BioStudies
1000-01-01 | S-EPMC5266794 | BioStudies
2013-01-01 | S-EPMC4015766 | BioStudies
1000-01-01 | S-EPMC4700759 | BioStudies
2019-01-01 | S-EPMC6922314 | BioStudies